Bisharat N, Omari H, Lavi I, Raz R. (2001). Risk of infection and death among post-splenectomy patients. J Infect. 2001 Oct;43(3):182-6. doi: 10.1053/jinf.2001.0904. PMID: 11798256.

Children’s Oncology Group. (2023). Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers, v. 6 (www.survivorshipguidelines.org).

Chisholm JC. (2007). Reimmunization after therapy for childhood cancer. Clin Infect Dis. 2007 Mar 1;44(5):643-5. doi: 10.1086/511650. Epub 2007 Jan 24. PMID: 17278053.

Guilcher GMT, Rivard L, Huang JT, et al. (2021) Immune function in childhood cancer survivors: a Children’s Oncology Group review. Lancet Child Adolesc Health. 2021 Apr;5(4):284-294. doi: 10.1016/S2352-4642(20)30312-6. Epub 2021 Feb 16. PMID: 33600774; PMCID: PMC8725381

Horwitz ME, Sullivan KM. (2006). Chronic graft-versus-host disease. Blood Rev. 2006 Jan;20(1):15-27. doi: 10.1016/j.blre.2005.01.007. Epub 2005 Apr 7. PMID: 16426941.

U.S. Centers for Disease Control and Prevention, Human Papillomavirus (www.cdc.gov/hpv/).

Van Tilburg CM, Sanders EA, Rovers MM, et al. (2006). Loss of antibodies and response to (re-) vaccination in children after treatment for acute lymphocytic leukemia: a systematic review. Leukemia. 2006 Oct;20(10):1717-22. doi: 10.1038/sj.leu.2404326. Epub 2006 Aug 3. PMID: 16888619.